Ana Nielson, OD
Optometrist · Meridian, IDNPI 1972547503
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,440 of the $4,689 with a category attached, or 73.4%. 14 manufacturers reported payments, led by Johnson & Johnson Surgical Vision, Inc. at 31.7% of the total. Reporting peaked in 2019 at $1,899 and has fallen 63.6% since, to $691 in 2025. Among optometrist clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 136 payments — averaging $34.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$1K
- Alcon$955
- Johnson & Johnson Vision Care, Inc.$694
- Tarsus Pharmaceuticals, Inc.$345
- Novartis$322
- Bausch & Lomb Americas Inc.$320
- plus $567 from 8 others
What the payments were for
- Travel & lodging$1,21726%
- Food & beverage$3,44073%
- Entertainment$331%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 12 | $1,486 |
| Alcon | 40 | $955 |
| Johnson & Johnson Vision Care, Inc. | 21 | $694 |
| Tarsus Pharmaceuticals, Inc. | 17 | $345 |
| Novartis | 15 | $322 |
| Bausch & Lomb Americas Inc. | 13 | $320 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 8 | $229 |
| Biotissue Holdings Inc. | 4 | $184 |
| Sun Pharmaceutical Industries Inc. | 1 | $39 |
| Optos, Inc. | 1 | $33 |
| Oyster Point Pharma, Inc. | 1 | $27 |
| Coopervision Inc. | 1 | $22 |
| Kala Pharmaceuticals, Inc. | 1 | $17 |
| Sight Sciences, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TearScience Lipiflow System$1,204
- TearScience Lipiview System$1,204
- TearScience Lipiscan System$1,204
- Acuvue$123
- Prokera$119
- AmnioGraft$119
- AmnioGuard$119
- XDEMVY$104
How this compares
$4,689 in reported general payments places this provider in the 95th percentile of 304 optometrist providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Timolol Maleate | 26 | $1,245 |
| Latanoprost | 25 | $60 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Meridian
- Jason BeseckerMeridian$29K
- Ryan NielsonMeridian$4K
- Renee RowleyMeridian$4K
- Joshua McAdamsMeridian$3K
- Russell GrayMeridian$3K
- Drew DaytonIdaho Falls$198K
- Philip RaineyBoise$175K
- Lavar KofoedBoise$91K
- William BlackCaldwell$67K
- Mark McKellNampa$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.